This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
One week after Agilent Technologies completed its $250 million acquisition of Stratagene, a company official said that he expects Stratagene’s molecular diagnostic collaborations to remain on track and that Agilent will be in close contact with those partners.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.